[1]曾德优,张六一,肖 创,等.慢性阻塞性肺疾病动物模型研究进展[J].陕西医学杂志,2022,51(4):507-510.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
 ZENG Deyou,ZHANG Liuyi,XIAO Chuang,et al.Research progress on animal models of chronic obstructive pulmonary disease[J].,2022,51(4):507-510.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.029]
点击复制

慢性阻塞性肺疾病动物模型研究进展
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年4期
页码:
507-510
栏目:
综 述
出版日期:
2022-04-05

文章信息/Info

Title:
Research progress on animal models of chronic obstructive pulmonary disease
作者:
曾德优1张六一1肖 创1王略力1黄 蓉1方 雁12杜晓华2Yusef Absi(约旦)1陈 晨1 杨为民1
(1.昆明医科大学药学院暨云南省天然药物药理重点实验室,云南 昆明 650500; 2.昆明医科大学第一附属医院,云南 昆明 650031)
Author(s):
ZENG DeyouZHANG LiuyiXIAO ChuangWANG LueliHUANG RongFANG YanDU XiaohuaYusef AbsiCHEN ChenYANG Weimin
(School of Pharmacy and Yunnan Key Laboratory of Natural Drug Pharmacology,Kunming Medical University,Kunming 650500,China)
关键词:
慢性阻塞性肺疾病 动物模型 香烟烟雾暴露 脂多糖 蛋白酶 呼吸道感染
Keywords:
Chronic obstructive pulmonary disease Animal model Cigarette smoke exposure Lipopolysaccharide Protease Respiratory tract infection
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7377.2022.04.029
文献标志码:
A
摘要:
慢性阻塞性肺疾病(COPD)已成为人类健康第三大杀手,迫切需要深入研究揭示其病理分子机制及防治药物。一般COPD分为稳定期及急性加重期COPD(AECOPD),目前在该领域尚未有统一的COPD、AECOPD动物模型造模方法。通过查阅近年来各类与COPD、AECOPD动物模型相关的文献,从单因素诱导方法和复合因素诱导方法两个方面综述几种比较常用的COPD、AECOPD动物模型造模方法,并简述其造模机制、方法及一些优缺点,为COPD动物模型建立和完善提供参考。
Abstract:
Chronic obstructive pulmonary disease(COPD)has become the third killer of human health.It is urgent to reveal its pathological molecular mechanism and preventive drugs.Generally,COPD is divided into stable phase and acute exacerbation phase(AECOPD).At present,there is no uniform method to establish animal models of COPD and AECOPD in this field.In this paper,we reviewed the literature related to the animal models of COPD and AECOPD in recent years,and summarized several commonly used animal models of COPD and AECOPD from two aspects:single-factor induction method and compound-factor induction method,the mechanism,method and some advantages and disadvantages of the model were briefly described to provide reference for the establishment and perfection of the COPD animal model.

参考文献/References:

[1] 黄纯美,刘小虹.中医药治疗慢性阻塞性肺疾病作用机制研究进展[J].陕西中医,2008,32(8):1098-1101.
[2] Ma N,Qi Y,Liang X,et al.Compare the effect of inhaled corticosteroids and systemic corticosteroids on sputum microbiome of AECOPD[J].Front Med(Lausanne),2021,26(2):637246.
[3] Zhu M,Peng H,Wan L,et al.The role of elevated red blood cell distribution width in the prognosis of AECOPD patients:A retrospective study[J].Medicine,2021,100(10):e25010.
[4] Jones B,Donovan C,Liu G,et al.Animal models of COPD:What do they tellus[J].Respirology,2017,22(1):21-32.
[5] Festing MF.Evidence should trump intuition by preferring inbred strains to outbred stocks in preclinical research[J].Ilar J,2014,55(3):399-404.
[6] Polverino F,Doyle-Eisele M,Mc-Donald J,et al.A novel nonhuman primate model of cigarette smoke-induced airway disease[J].Am J Pathol,2015,185(3):741-755.
[7] Li D,Xu ZB,Wang HC,et al.Research new progress of smoking on airway gene expression in chroic obstructive pulmonary disease[J].Inter Jour of Res,2011,17:1323-1327.
[8] Wang G,Mohammadtursun N,Sun J,et al.Establishment and evaluation of a rat model of sidestream cigarette smoke-induced chronic obstructive pulmonary disease[J].Front Physiol,2018,6(2):58.
[9] Xiao C,Cheng S,Lin HC,et al.Isoforskolin,an adenylyl cyclase activator,attenuates cigarette smoke-induced COPD in rats[J].Phy Avail Online,2021,8:153701.
[10] Beckett EL,Stevens RL,Jarnicki AG,et al.A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis[J].J Allergy Clin Immunol,2013,131:752-762.
[11] Miller M,Cho JY,Pham A,et al.Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years[J].Chest,2011,139(6):1380-1387.
[12] Matwyoff GN,Prahl JD,Miller RJ,et al.Immune regulation of procalcitionin:A biomarker and mediator of infection[J].Inflamm Res,2012,61(5):401-409.
[13] Nagavedi SU,Joyce G,Sadanand F,et al.β-Nicotinamide adenine dinucleotide attenuates lipopolysaccharide-induced inflammatory effects in a murine model of acute lung injury[J].Exp Lung Res,2012,38(5):223-232.
[14] Brass DM,Hollingsworth JW,Cinque M,et al.Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis[J].Am J Resp Cell Mol Biol,2008,39:584-590.
[15] Kao ST,Liu CJ,Yeh CC.Protective and immunomodulatory effect of flos lonicerae japonicae by augmenting IL-10 expression in a murine model of acute lung inflamm ation[J].J Ethnopharmacol,2015,168:108-115.
[16] Zhou Y,Fang H,Lin S,et al.Qiliqiangxin protects against cardiac ischemia repeffusion injury via activation of the mTOR pathway[J].Cell Physiol Biochem,2015,37(2):454-464.
[17] Wang XM,Mu CZ,Mu TC,et al.Effects of Tongxinluo on myoeardial fibrosis in diabetic rats[J].J Chin Med Assoc,2016,79(3):130-136.
[18] Lüthje L,Raupach T,Michels H,et al.Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model[J].Respir Res,2009,10:7.
[19] Ueno M,Maeno T,Nishimura S,et al.Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages[J].Nat Commun,2015,6:6332.
[20] Rohrer J,Wuertz BR,Ondrey F.Cigarette smoke condensate induces nuclear factor kappab activity and proangiogenic growth factors in aerodigestive cells[J].Laryngoscope,2010,120(8):1609-1613.
[21] Donovan C,Seow HJ,Bourke JE,et al.Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to beta-adrenoceptor agonists in mouse lung[J].Clin Sci(Lond),2016,130(10):829-837.
[22] Hsu AC,Starkey MR,Hanish I,et al.Targeting PI3K-p110α suppresses influenza virus infection in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2015,191(9):1012-1023.
[23] Wen W,Lai GX,Zheng HP,et al.Induction of rat model of chronic obstructive pulmonary disease by repeated infection with pseudomonas aeruginosa[J].Acta Lab Animalis Sci Sin,2011,19(5):415-418.
[24] Ganesan S,Fails AN,Comstock AT,et al.Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge:Role of scavenger receptor A[J].Am J Pmhol,2012,180(1):61-72.
[25] Doiron D,Hoogh K,Probst-Hensch N,et al.Air pollution,lung function and COPD:Results from the population-based UK Biobank study[J].Eur Respir J,2019,54(1):1802140.
[26] Ghozikali MG,Mosaferi M,Safari GH,et al.Effect of exposure to O3,NO2,and SO2 on chronic obstructive pulmonary disease hospitalizations in Tabriz,Iran[J].Environ Sci Pollut Res Int,2015,22(4):2817-2823.
[27] Gao W,Yuan C,Zhang J,et al.Klotho expression is reduced in COPD airway epithelial cells:Effects on inflammation and oxidant injury[J].Clin Sci,2015,129(12):1011-1023.
[28] Wu S,Deng F,Hao Y,et al.Fine particulate matter,temperature,and lung function in healthy adults:Findings from the HVNR study[J].Chemosphere,2014,108:168-174.
[29] Bossé Y.Updates on the COPD gene list[J].Int J Chron Obstruct Pulmon Dis,2012,7:607-631.
[30] Richmond BW,Brucker RM,Han W,et al.Airway bacteria drive a progressive COPD like phenotype in mice with polymeric immunoglobulin receptor deficiency[J].Nat Commun,2016,7:11240.
[31] Borel F,Sun H,Zieger M,et al.Editing out five serpina1 paralogsto create a mouse model of genetic emphysema[J].Proc Natl Acad Sei USA,2018,1159(11):2788-2793.
[32] Li Y,Li SY,Li JS,et al.A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection[J].Biol Pharm Bull,2012,35(10):1752-1760.
[33] Shin IS,Shin NR,Park JW,et al.Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via thesuppression of Erk-Spl signaling[J].J Pineal Res,2015,58(1):50-60.
[34] Lee J,Taneja V,Vassallo R.Cigarette smoking and inframmation cellular and molecular mechanisms[J].J Dent Res,2012,91(2):142-149.
[35] 张卓红,赵拖利.慢性阻塞性肺疾病大鼠血液、支气管灌洗液中水通道蛋白及p-c-Jun-N-末端激酶表达情况实验研究[J].陕西医学杂志,2021,50(7):776-779.
[36] Saluja B,Li H,Desai UR,et al.Sulfated caffeic acid dehydropolymer attenuates elastase and cigarette smoke extract-induced emphysema in rats:Sustained activity and a need of pulmnonary delivery[J].Lung,2014,192(4):481-492.
[37] Rice MB,Ljungman PL,Wilker EH,et al.Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study[J].Am J Respir Crit Care Med,2015,191(6):656-664.
[38] Gu XY,Chu X,Zeng XI,et al.Effects of PM 2.5 exposure on the notch signaling pathway and immune imbalance in chronic obstructive pulmonary diseases[J].Environ Pollut,2017,226:163-173.
[39] Chu X,Liu XJ,Qiu JM,et al.Effects of astragalus and codonopsis pilosula polysaccharldcs on alveolar macrophage phagocytosis and infIammation in chronic obstructive pulmonary disease mice exposed to PM 2.5[J].Environ Toxicol Pharmacol,2016,48:76-84.
[40] Butler CC,Gillespie D,White P,et al.C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations[J].N Engl J Med,2019,381(2):111-120.
[41] 陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102-104.
[42] Vlahos R,Bozinovski S.Recent advances in pre-clinical mouse models of COPD[J].Clin Sci,2014,126(4):253.
[43] Xiao C,Cheng S,Li R,et al.Isoforskolin Alleviates AECOPD by improving pulmonary function and attenuating inflammation which involves downregulation of Th17/IL-17A and NF-κB/NLRP3[J].Front Pharmacol,2021,30(7):721273.
[44] 张甜甜,田王斌,李媛媛,等.烟熏联合不同细菌建立大鼠慢性阻塞性肺疾病急性加重期动物模型[J].中华实用诊断与治疗杂志,2018,3(8):743-746.
[45] Huang QS,Yang HJ,Zhang CT,et al.Xiaoqinglong decoction protects the lungs of AECOPD mice through the AMPK/mTOR signaling pathway[J].Evid Based Complement Alternat Med,2020,4:9865290.
[46] 余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223-1226.

相似文献/References:

[1]马明铭,李 芳,杨 慧,等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响[J].陕西医学杂志,2019,(4):515.
 MA Mingming,LI Fang,YANG Hui,et al.Effect of tiotropium bromide powder and nonpharmacological rehabilitation program on BODE index in patients with chronic obstructive pulmonary disease[J].,2019,(4):515.
[2]朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期〖JZ〗伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,(10):1353.
 ZHU Xiaochuan..Clinical value of platelet/lymphocyte ratio in predicting early renal impairment〖JZ〗 in acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(4):1353.
[3]张军营.吸烟对慢阻肺患者血清S100A8/A9、8异前列腺素F2α、组织蛋白酶S及其它炎症因子表达水平的影响*[J].陕西医学杂志,2019,(11):1426.
[4]焦文妤,尚家璐,李树霞△.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,(12):1616.
[5]陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102.
[6]薛佩妮,冯敏娟△,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响*[J].陕西医学杂志,2020,49(2):216.
 XUE Peini,FENG Minjuan,WANG Huiqin..Efficacy of tiotropium bromide combined with glucocorticoids in the treatment of COPD and its effect on patients' quality of life score[J].,2020,49(4):216.
[7]刘 宾,崔 鑫,秦傲霜,等.封闭式负压治疗对改善美容缝合伤口愈合质量的实验研究*[J].陕西医学杂志,2020,49(5):553.
 LIU Bin,CUI Xin,QIN Aoshuang,et al.Effect of closed negative pressure therapy on improving the quality of cosmetic suture wound healing[J].,2020,49(4):553.
[8]蔡碧莲,文亦磊△,罗伟生△.大鼠肝纤维化实验动物模型的构建*[J].陕西医学杂志,2020,49(6):659.[doi:DOI:10.3969/j.issn.10007377.2020.06.005]
[9]刘翔宇,王凌云.环杷明抑制肝星形细胞激活改善肝纤维化作用实验研究*[J].陕西医学杂志,2020,49(6):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
 LIU Xiangyu,WANG Lingyun..Effect of cyclopamine on inhibiting the activation of hepatic astrocyte and improving hepatic fibrosis[J].,2020,49(4):663.[doi:DOI:10.3969/j.issn.10007377.2020.06.006]
[10]艾丁丁,罗伟生△,蒋云霞.动物肝纤维化模型建立研究进展*[J].陕西医学杂志,2020,49(7):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]
 AI Dingding,LUO Weisheng,JIANG Yunxia..Progress in the establisment of animal liver fibrosis model[J].,2020,49(4):907.[doi:DOI:10.3969/j.issn.10007377.2020.07.038]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81870037); 云南省科技厅科研项目(202005AF150043,202005AE160004,2019FD020)
更新日期/Last Update: 2022-04-07